ArticleThe oncologist2024

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée).

Perrine Rousset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.